Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
14
|
| pubmed:dateCreated |
1996-10-31
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0098-7484
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
9
|
| pubmed:volume |
276
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1140
|
| pubmed:dateRevised |
2006-11-7
|
| pubmed:meshHeading |
pubmed-meshheading:8827965-Anti-HIV Agents,
pubmed-meshheading:8827965-Anti-Infective Agents,
pubmed-meshheading:8827965-Area Under Curve,
pubmed-meshheading:8827965-Biological Availability,
pubmed-meshheading:8827965-Drug Interactions,
pubmed-meshheading:8827965-Humans,
pubmed-meshheading:8827965-Lamivudine,
pubmed-meshheading:8827965-Trimethoprim
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Effect of trimethoprim on lamivudine bioavailability.
|
| pubmed:publicationType |
Letter,
Comment
|